| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $79.5M | +40.2% |
| SG&A Expense | $38.8M | +67.1% |
| Operating Income | -$118.3M | -48.0% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$118.0M | -46.0% |
| EPS (Basic) | -$2.26 | -29.1% |
| EPS (Diluted) | -$2.26 | -29.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.9M | -42.0% |
| Short-term Investments | $289.7M | -1.4% |
| Current Assets | $404.0M | -16.5% |
| Total Assets | $461.2M | -15.1% |
| Current Liabilities | $20.8M | +42.7% |
| Total Liabilities | $50.0M | +12.6% |
| Stockholders' Equity | $411.2M | -17.5% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.2M | -33.9% |
| Capital Expenditures | $2.3M | -2.3% |
| Investing Cash Flow | -$1.8M | +99.0% |
| Financing Cash Flow | $6.6M | -98.2% |
| Free Cash Flow | -$84.5M | -32.5% |